• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】13845

【品名】methyl 5-[(3aS,5R,6S,6aS)-5-hydroxy-6-[(1E,3S,5Z)-3-hydroxy-1,5-octadienyl]-1,3a,4,5,6,6a-hexahydro-2-pentalenyl]pentanoate

【CA登记号】

【 分 子 式 】C22H34O4

【 分 子 量 】362.50956

【元素组成】C 72.89% H 9.45% O 17.65%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(CXIX)

13) The synthesis of the 17,18-ditritiated clinprost can be performed as follows: The reduction of the bicyclic aldehyde (LIII) described in Scheme 4 with NaBH4 in methanol gives the hydroxymethyl derivative (CXIII), which is esterified with methyl chloroformate yielding the carbonate ester (CXIV). The condensation of (CXIV) with 4,4-bis(phenylsulfonyl)butyric acid methyl ester (XCV) catalyzed by a palladium complex in THF affords the expected alkylation product (CXV), which is treated with Mg in methanol to eliminate the phenylsulfonyl groups, giving the unsaturated pentanoic acid methyl ester derivative (XLV) already obtained in Scheme 3. The desilylation of (XLV) with TBAF followed by oxidation with SO3/Pyr yields the aldehyde (XLVI), also reported in Scheme 3. The reaction of (XLVI) with dimethyl 2-oxo-4(Z)-heptenylphosphate (CXVI) by means of NaH in THF affords the expected condensation product (CXVII), which is regioselectively reduced with LiAlH4 in THF in the presence of (S)-(-)-binaphthol to give the (Z)-17,18-didehydro-11-O-tetrahydropyranylclinprost (CXVIII). Elimination of the THP group of (CXVIII) with acetic acid in THF/water yields the (Z)-17,18-didehydroclinprost (CXIX), which is finally tritiated by hydrogenation with tritium gas in benzene/cyclohexane using tris(triphenylphosphine)rhodium(I) chloride as catalyst. 14) If the final reduction of (CXIX) is performed with hydrogen gas in benzene/cyclohexane containing cyclododecene and in the presence of a Pd/C catalyst, clinprost is obtained.

1 Graul, A.; Leeson, P.; Castaner, J.; Clinprost. Drugs Fut 1997, 22, 6, 608.
2 Manabe, K.; Tanaka, T.; Kurozumi, S.; Kato, Y.; Syntheses of di-tritiated 9(O)-methane-DELTA6(9alpha)-prostaglandin I1 methyl esters. J Label Compd Radiopharm 1991, 29, 10, 1107-19.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(CXIII) 13838 [(3aS,5R,6R,6aS)-6-([[tert-Butyl(dimethyl)silyl]oxy]methyl)-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1,3a,4,5,6,6a-hexahydro-2-pentalenyl]methanol C22H40O4Si 详情 详情
(CXIV) 13839 [(3aS,5R,6R,6aS)-6-([[tert-butyl(dimethyl)silyl]oxy]methyl)-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1,3a,4,5,6,6a-hexahydro-2-pentalenyl]methyl methyl carbonate C24H42O6Si 详情 详情
(CXV) 13841 methyl 5-[(3aS,5R,6R,6aS)-6-([[tert-butyl(dimethyl)silyl]oxy]methyl)-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1,3a,4,5,6,6a-hexahydro-2-pentalenyl]-4,4-bis(phenylsulfonyl)pentanoate C39H56O9S2Si 详情 详情
(CXVI) 13842 dimethyl (Z)-2-oxo-4-heptenylphosphonate C9H17O4P 详情 详情
(CXVII) 13843 methyl 5-[(3aS,5R,6S,6aS)-6-[(1E,5Z)-3-oxo-1,5-octadienyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1,3a,4,5,6,6a-hexahydro-2-pentalenyl]pentanoate C28H42O5 详情 详情
(CXVIII) 13844 methyl 5-[(3aS,5R,6S,6aS)-6-[(1E,3S,5Z)-3-hydroxy-1,5-octadienyl]-5-[(tetrahydro-2H-pyran-2-yloxy)methyl]-1,3a,4,5,6,6a-hexahydro-2-pentalenyl]pentanoate C28H44O5 详情 详情
(CXIX) 13845 methyl 5-[(3aS,5R,6S,6aS)-5-hydroxy-6-[(1E,3S,5Z)-3-hydroxy-1,5-octadienyl]-1,3a,4,5,6,6a-hexahydro-2-pentalenyl]pentanoate C22H34O4 详情 详情
(XCV) 13819 methyl 4,4-bis(phenylsulfonyl)butanoate C17H18O6S2 详情 详情
Extended Information